Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer

BACKGROUND: The understanding of molecular changes in mCRC during treatment could be used to personalise therapeutic strategies. The aim of our study was to explore the association of circulating tumour DNA (ctDNA) with clinical outcome in metastatic colorectal cancer (mCRC). METHODS: Sequential pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Ning, Chang, Lianpeng, Gao, Xin, Shi, Xiaohua, Dou, Xuelin, Guan, Mei, Shao, Yajuan, Li, Ningning, Cheng, Yuejuan, Ying, Hongyan, Sun, Zhao, Zhou, Yanping, Zhao, Lin, Zhou, Jianfeng, Bai, Chunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296534/
https://www.ncbi.nlm.nih.gov/pubmed/34294055
http://dx.doi.org/10.1186/s12885-021-08309-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296534/
https://www.ncbi.nlm.nih.gov/pubmed/34294055
http://dx.doi.org/10.1186/s12885-021-08309-2

Ejemplares similares